Status: current, Defined. Date: 30-Sep 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2534631000168110 | Rivastigmine (Apo) (rivastigmine 4.5 mg) capsule, 100 capsules, bottle (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2534641000168118 | Rivastigmine (Apo) 4.5 mg capsule, 100, bottle | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Rivastigmine (Apo) 4.5 mg capsule, 100, bottle | Is a | Rivastigmine (Apo) 4.5 mg capsule, 100 | true | Inferred relationship | Some | ||
| Rivastigmine (Apo) 4.5 mg capsule, 100, bottle | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Rivastigmine (Apo) 4.5 mg capsule, 100, bottle | has TPUU | Rivastigmine (Apo) 4.5 mg capsule | true | Inferred relationship | Some | 1 | |
| Rivastigmine (Apo) 4.5 mg capsule, 100, bottle | has container type | bottle | true | Inferred relationship | Some | ||
| Rivastigmine (Apo) 4.5 mg capsule, 100, bottle | has TP | Rivastigmine (Apo) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR